COMMUNIQUÉS West-GlobeNewswire

Agomab Announces Pricing of Initial Public Offering
06/02/2026
ANTWERP, Belgium, February 5, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology [...]
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
05/02/2026
52% Amtagvi Response Rate with Two or Fewer Prior Lines of Therapy 73% Overall Disease Control Rate SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial [...]
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
05/02/2026
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the following two upcoming investor conferences: TD Cowen 46 th [...]
PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026
06/02/2026
An informational overview examining compounded semaglutide vs FDA-approved GLP-1 medications, telehealth platform evaluation criteria, and what consumers consider when researching prescription weight management [...]
Teladoc Health to Announce Fourth Quarter 2025 Financial Results
05/02/2026
NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the [...]
CooperCompanies Announces Release Date for First Quarter 2026
05/02/2026
SAN RAMON, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report first quarter 2026 financial results on Thursday, March 5, 2026, at 4: [...]
Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
05/02/2026
HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
05/02/2026
SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
His Choice Health Announces Opening of New Charlotte Clinic, Expanding Access to Trusted, Patient-Centered Men’s Health Care
06/02/2026
Regional Growth Following Raleigh–Durham Brand Unification CHARLOTTE, NC, Feb. 05, 2026 (GLOBE NEWSWIRE) -- His Choice Health today announced the upcoming opening of its newest clinic in Charlotte, targeted late [...]
Coeptis Receives Shareholder Approval Towards Z Squared Merger
05/02/2026
Shareholder Approval Clears a Key Condition to Close WEXFORD, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/02/2026
WESTLAKE VILLAGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update
05/02/2026
February 5, 2026 Announcement no. 1 BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update COPENHAGEN, DENMARK, February 5, 2026, (GLOBE NEWSWIRE) – BioPorto A/ [...]
Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™
05/02/2026
Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrum Launch readiness established in [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
05/02/2026
Bagsværd, Denmark, 5 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Cross Medical Group Announces New Villanova Office Location
05/02/2026
Move Reflects the Philadelphia Area Practice’s Ongoing Commitment to Patient Care VILLANOVA, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cross Medical Group, a cosmetic surgery practice specializing in procedures for the [...]
Introducing Community by Keto-Mojo – A Supportive, Expert-Led Space to Help People Succeed in Ketosis and Beyond
05/02/2026
NAPA, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sustainable health doesn’t happen in isolation—it thrives in community. While millions attempt keto, low-carb, or fasting lifestyles to improve their metabolic health, [...]
Blueprint for Action Calls for Pan-Canadian Leadership to Close the Women’s Health Gap
05/02/2026
New national plan outlines how Canada can improve women’s health, strengthen participation, and unlock economic gains TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (WHCC) today released [...]
Virbac : Declaration of the number of shares and voting rights 01/2026
05/02/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Le plan d’action Diriger pour combler l’écart demande aux acteurs au pouvoir partout au pays de réduire les disparités en matière de santé des femmes
05/02/2026
Un nouveau plan national présente comment le Canada peut améliorer la santé des femmes et renforcer leur participation à la société afin de faire de nouveaux gains économiques TORONTO, 05 févr. 2026 (GLOBE NEWSWIRE) -- [...]

Pages